Christophe Mallard

Christophe Mallard is the founder of Eigen Capital, LLC, a Palo Alto–based private investment firm he established around 2009–2011. Eigen Capital focuses on acquiring non-core assets — divisions and subsidiaries divested by large corporations — with the stated aim of refocusing them, restoring growth, and building them into standalone "world-class" companies. The firm's model emphasizes a longer holding horizon and deeper operational resource commitment than a traditional buyout fund, and it is staffed by executives with prior CEO-level operating experience.

Before founding Eigen Capital, Mallard built a career spanning investment banking and private equity. Directory and investor-database records list prior roles at Deutsche Bank / DB Capital, UBS Securities (and UBS Investment Bank), Platinum Equity, and H.I.G. Capital, giving him a background that combines corporate finance with hands-on carve-out and turnaround investing — the exact skill set Eigen Capital applies to corporate divestitures.

Mallard has also served in an operating capacity: he was Chief Executive Officer of Monarch Medical Technologies, a digital-health company focused on insulin-dosing/glycemic-management software, reflecting the firm's practice of its principals taking direct leadership of portfolio businesses.

On the education side, he studied at HEC Paris (1992–1994) and holds an undergraduate degree from the University of Liège in Belgium.

• Buy corporate orphans, not startups: Eigen Capital targets "acquisitions of divisions or subsidiaries of large corporations" — non-core assets that a parent no longer prioritizes — rather than venture/seed-stage companies.
• Value creation through operating focus: The stated goal is to "revitalize growth" and transform acquired units into "world-class companies," creating value through both organic growth and add-on acquisitions, to the benefit of customers, suppliers, employees, and shareholders.
• Deal types: Middle-market buyouts, turnarounds, corporate spin-offs, and divestitures.
• Operator-led: The firm is built around principals who have been CEOs and investors, and who commit longer time horizons and more operating resources than a conventional PE fund.
• Broad sector mandate: Healthcare/life sciences, industrials, materials, consumer staples, business services, transportation & logistics, retail/consumer, energy, communications, and IT.